ICO.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Devices

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$29M	+203.7%	$-0.46	$-0.46–$-0.46	—	1
2027	$2M	-93.1%	$-0.38	$-0.38–$-0.38	—	1
2028	$37M	+1750.0%	$-0.38	$-0.38–$-0.38	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.05

Price

$1.25

Implied downside

-96%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ICO.STIconovo AB (publ)	$1.25	+1.22%	$65M	—
ACTI.STActive Biotech AB	$4.21	+2.80%	$111M	—
ARCOMA.STArcoma AB	$8.20	+3.02%	$117M	—
BIOVIC-B.STBiovica International AB (publ)	$0.31	+1.31%	$86M	—
HEART.STScandinavian Real Heart AB (Publ)	$17.70

Iconovo AB (publ)

Based in Lund, Sweden, Iconovo AB (publ) focuses on the creation and licensing of advanced inhalation delivery systems. Their product portfolio encompasses a variety of dry powder inhalers, such as the versatile multi-dose ICOres, the capsule-driven ICOcap, the single-use disposable ICOone, and the pre-metered ICOpre. Beyond these standard devices, the company also designs custom inhalation solutions, primarily catering to generic pharmaceutical firms. Iconovo is involved in significant collaborative ventures, including a project with Immune System Regulation AB to develop an inhaled COVID-19 vaccine using their ICOone inhaler, and a partnership with Respiratorius AB (publ) to formulate an inhalation treatment for COPD. The company was established in 2013.

www.iconovo.se

Employees: 12
IPO / List date: Apr 6, 2018
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds ICO.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ICO.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ICO.ST yet.